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Many cell types express a membrane receptor, activated by trypsin-like proteases, termed protease-activated re-
ceptor-2 (PAR-2). Previous studies describing PAR-2 expression on ﬁbroblasts have been conﬂicting. In this report,
we investigated in vitro PAR-2 expression on several ﬁbroblast cell lines using ﬂow cytometry, immunohistology,
and immunoblots of cell lysates. Consistent PAR-2 expression was detected in cultured ﬁbroblasts, although we
observed heterogeneity of cellular expression among the cell lines. Some ﬁbroblast lines expressed PAR-2 pre-
dominantly as an intracellular protein with differing cytoplasmic staining patterns, whereas other ﬁbroblast lines
displayed PAR-2 primarily as a cell surface receptor. Immunoblots of cell lysates with polyclonal anti-PAR-2 dem-
onstrated a 44 kDa band, the predicted molecular weight for the PAR-2 core protein. Furthermore, we noted that
expression of PAR-2 was subject to regulation. Fibroblasts grown within a collagen matrix downregulated receptor
expression whereas increased PAR-2 expression was observed by the addition of ﬁbroblast growth factors PDGF-
BB and TGF-b. This study may explain the previous inconsistencies in PAR-2 expression observed on tissue
ﬁbroblasts. Results indicate that the degree of ﬁbroblast proliferation, attenuated by extracellular matrix and
upregulated by growth factors, inﬂuences whether ﬁbroblasts express PAR-2 and, thus, would be responsive to
protease signaling.
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It is well established that serine proteases, such as thrombin,
can exert cytokine-like effects on human tissue fibroblasts.
This has largely been attributed to their ability to initiate
signaling via protease-activated receptors (PAR) expressed
by tissue fibroblasts (Hollenberg and Compton, 2002). More
recently, evidence has emerged demonstrating the capacity
of mast cell-derived proteases such as tryptase to activate
fibroblasts (Ruoss et al, 1991). Initially, the mechanism by
which tryptase stimulated fibroblasts was unknown, espe-
cially since tryptase lacked the ability to activate the clas-
sical thrombin receptor (PAR-1). Shortly thereafter, following
the discovery of a second protease-activated receptor
(PAR-2), several independent investigators demonstrated
that tryptase can cleave and activate PAR-2 (Corvera et al,
1997; Mirza et al, 1997; Molino et al, 1997; Schechter et al,
1998; Steinhoff et al, 1999; Compton et al, 2001; Akers et al,
2002). PAR-2, however, was noted to be expressed pre-
dominantly on cells of epithelial or endothelial origin, with
prior reports documenting a virtual absence of PAR-2 mRNA
and protein expression on fibroblasts (Santulli et al, 1995;
D’Andrea et al, 1998). Further studies by other investigators
demonstrated weak expression on dermal fibroblasts but in
contradistinction more consistent PAR-2 expression in lung
parenchymal or airway-derived fibroblasts (Schechter et al,
1998; Steinhoff et al, 1999; Akers et al, 2002). Thus, the
mechanism by which mast cell-derived tryptase activates
fibroblasts has remained puzzling and led some investiga-
tors to postulate that a separate (yet to be identified) try-
ptase-activated receptor exists on fibroblasts (Akers et al,
2002).
The uncertainty concerning fibroblast expression of PAR-
2 remains largely unresolved despite the considerable body
of evidence that has accrued portraying a role for mast cell–
fibroblast interactions, and specifically, tryptase activation
of fibroblasts (Gruber et al, 1997). Some insight into this
ambiguity surfaced with the finding of PAR-2 expression
in situ specifically on proliferating fibroblasts within the stroma
immediately surrounding neoplasms or healing wounds
(D’Andrea et al, 2001). These observations raise the intrigu-
ing possibility that human fibroblasts have the capacity to
express PAR-2 as an inducible membrane protein, perhaps
stimulated by growth factors and regulated by extracellular
matrix. In this investigation, we demonstrate the capacity of
human fibroblasts to express PAR-2 in vitro and character-
ize the factors that govern this expression.Abbreviation: PAR, protease-activated receptors
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Results
PAR-2 expression on cultured ﬁbroblasts Immunohisto-
logical analysis revealed consistent PAR-2 staining, al-
though distinct patterns were observed. Two cell lines of
fibroblasts were selected for more detailed analysis as dif-
ferences in PAR-2 expression emerged. Fibroblasts 4392A
expressed a substantial amount of membrane staining as
compared to 2261B that predominantly expressed PAR-2
as an intracellular protein (Fig 1A). Furthermore, different
patterns of intracellular staining were evident. Within the
2261B fibroblasts, a proximal perinuclear pocket staining
pattern was observed (Fig 1B, left panel ). Other cells dis-
played a fine and coarse granular cytoplasmic pattern
(Fig 1B, center panel ) with vesicular intracytoplasmic stain-
ing (Fig 1B, right panel ). The staining of vesicle-like struc-
tures with PAR-2 was similar to that previously described to
be associated with the golgi apparatus in rat kidney cells
(Dery et al, 1999).
Flow cytometry analysis The fibroblasts 4392A and
2261B were subjected to flow cytometry following disper-
sion from the culture flasks for quantitative evaluation of
PAR-2 expression. Flow cytometry analysis confirmed dif-
ferences in the distribution of PAR-2 between 4392A and
2261B cells (Fig 2). Whereas the majority (70%) of 4392A
cells expressed surface PAR-2, only a subset (25%) of
2261B cells were positive (p¼0.0001, N¼ 7–8). Moreover,
the surface level of PAR-2 was significantly increased on a
per cell basis, as indicated by the intensity of fluorescence
(noted by both microscopic and flow cytometric analysis).
Although 2261B did not demonstrate prominent surface
staining, intracellular expression was strong in these cells
(Fig 2A). Interestingly, despite the markedly different ana-
tomical localization of PAR-2, the total level (surface plus
intracellular) of PAR-2 was not significantly different be-
tween 4392A and 2261B cells (85% vs 79%, respectively,
p¼0.3, N¼8–10). The total level of fluorescence on a per
cell basis was also not altered.
Two-color analysis by flow cytometry revealed that most
of the cultured 4392A and 2261B cells expressed smooth
muscle actin in conjunction with PAR-2 (Fig 3), possibly re-
flecting a myofibroblast-like phenotype. In addition, a cor-
relation between PAR-2 expression and proliferation was
suggested by a double staining pattern observed on fibro-
blasts co-expressing PAR-2 and Ki67, a nuclear cell prolif-
eration-associated marker (data not shown).
Immunoblot analysis of PAR-2 expression Immunoblot
analysis of PAR-2 protein expression on detergent-soluble
lysates derived from various fibroblast cell lines originating
from different organs is demonstrated in Fig 4. The survey
included different fibroblast cultures from adult skin (includ-
ing 2261B), neonatal skin, fetal skin (including 4392A), adult
lung, and fetal lung. The fibroblast cultures all expressed
measurable levels of PAR-2. In this analysis, we observed
PAR-2 core protein at the expected molecular size of 44
kDa (Fig 4), as well as higher molecular weight immuno-
reactive bands (not shown). The higher molecular weight
forms may possibly represent fully glycosylated receptors
Figure 1
Cellular distribution of PAR-2 in fibroblast
lines. (A) Fibroblasts 4392A (upper panels) and
2261B (lower panels) were grown on slides,
fixed, permeablized and stained with either
isotype-matched controls (left panels) or mAb
to PAR-2 in situ (center panels). In addition,
fibroblasts were stained in suspension to
monitor surface PAR-2 expression, deposited
onto slides, and counterstained with propidium
iodide (PI) (right panels). Fluorescence micros-
copy revealed a pattern of PAR-2 expression
primarily on the surface in 4392A fibroblasts,
whereas predominant intracellular staining was
observed in 2261B fibroblasts. Original magnifi-
cation,  40 (B) Sub-confluent cultures of
2261B fibroblasts grown in chamber slides were
stained with mAb to PAR-2 and counterstained
with PI. Analysis by confocal microscopy re-
vealed distinct patterns of intracellular PAR-2 in-
cluding pockets distributed proximal to the
nucleus (left panel) as well as cytoplasmic fine
and course granules (central panel ). Higher mag-
nification of the coarse granules showed them to
resemble vesicles (right panel ).
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as previously described (Compton et al, 2001). Pre-absorp-
tion experiments using anti-PAR-2 blocking peptide, how-
ever, failed to diminish the expression of these higher
immunoreactive bands. Thus, we have focused on the 44
kDa form since pre-treatment of anti-PAR-2 with its specific
blocking peptide completely abrogated this immunoreac-
tive band (data not shown). Variability of PAR-2 expression
in quantitative terms seemed largely independent of tissue
source and chronological age of tissue donor (data not
shown). The number of population doublings also did not
appear to affect PAR-2 expression in vitro, with stable pat-
terns noted up to 37 PDLs (data not shown).
PAR-2 expression is inducible and regulated Because
PAR-2 expression was observed as a consistent property of
all fibroblasts studied under cultured conditions, but yet
rarely expressed normally in situ, we next investigated the
possibility that extracellular matrix regulated PAR-2 expres-
sion. Our initial efforts involved culturing the cells layered
onto collagen to allow a 2-dimensional exposure to extra-
cellular matrix. No alteration in PAR-2 expression was ob-
served (Fig 5A). We also studied the effect of cultures
exposed in a similar manner to fibronectin and likewise ob-
served minimal effects (Fig 5A). In an effort to more closely
replicate fibroblasts in vivo, we next embedded the fibro-
blasts within a three-dimensional collagen matrix. Using this
culture system, we noted a marked decrease in PAR-2 ex-
pression within 24 h of exposure that continued to diminish
over 48 h (Fig 5B). PAR-2 expression was essentially ab-
rogated by 48 h in both the 4392A and 2261B cell lines,
Figure 2
Flow cytometric analysis of differential PAR-2
expression by fibroblast lines. Fibroblasts
4392A (left panels) and 2261B (right panels) were
stained in suspension for surface (upper panels)
PAR-2 expression and total cellular PAR-2 ex-
pression using permeablized cells (lower panels),
as described in methods section. (nX7 for each
group).
Figure 3
Fibroblast lines co-express PAR-2 and
smooth muscle actin (SMA) indicative of my-
ofibroblast morphology. Fixed and permeabli-
zed 2261B fibroblasts (upper panels) and 4392A
fibroblasts (lower panels) were double stained
with isotype controls (left panels) or antibody to
PAR-2 and SMA (right panels) and analyzed by
flow cytometry as described in Materials and
Methods. Figure shown is representative of two
experiments giving identical results.
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although a slight variation in kinetics was noted between the
two lines (Fig 5B). Prolonged culture over 10 days had min-
imal effect, with no further appearance or re-emergence of
PAR-2 after 72 h (data not shown). In further support of the
data obtained by immunoblot analysis, immunocytochem-
istry confirmed downregulation of PAR-2 after fibroblasts
were embedded in a collagen matrix system (Fig 5C). In this
analysis, decreases in both intracellular and surface PAR-2
expression were clearly evident on 2261B and 4392A cells,
respectively. In order to mimic in vivo conditions, we further
studied PAR-2 expression in an organotypic keratin-
ocyte:fibroblast 3-dimensional matrix culture system as
previously described (Garlick and Taichman, 1994; Gruber
et al, 1997). Immunostaining of frozen sections demonstrat-
ed keratinocyte but no fibroblast staining (data not shown).
Since collagen three-dimensional culture systems ap-
peared to downregulate the PAR-2 expression mimicking
the typical in vivo situation, we next studied the effect of
growth factors on upregulating PAR-2 expression. Our initial
efforts monitored the effects of platelet-derived growth fac-
tor-BB and transforming growth factor-b in stimulating PAR-
2 expression on fibroblasts cultured under standard condi-
tions. As indicated in Fig 6, PAR-2 expression was again
noted under basal conditions but increased after a 72 h
exposure to TGF-b and substantially more when exposed to
PDGF-BB. Treatment with both growth factors together
yielded a small additional effect (Fig 6). In contrast, expo-
sure to tumor necrosis factor-a and interleukin 1-a resulted
in no alteration in fibroblast PAR-2 expression (data not
shown). A dose response to PDGF-BB (Fig 7), as well as a
time course (not shown) for upregulation of PAR-2 expres-
sion was observed in cultured fibroblasts. A dose depend-
ency was observed to PDGF-BB for concentrations up to
30 ng per mL (Fig 7), with a time course indicating maximal
expression by 24 h (not shown). We next investigated the
effect of these growth factors when added to fibroblasts in
three-dimensional collagen matrix where PAR-2 expression
was downregulated. As shown in Fig 8, PDGF-BB was ca-
pable of stimulating PAR-2 fibroblast expression within the
collagen matrix culture system. In fact, we noted that by
48 h exposure to PDGF-BB the expression of PAR-2 was
similar to that noted when the cells were grown on plastic in
the absence of collagen (Fig 8). Finally, the effect of a three-
dimensional collagen matrix and PDGF-BB on fibroblast
PAR-2 mRNA was analyzed by RT-PCR (Fig 9). There is a
clear PDGF-induced increase in PAR-2 mRNA both in cells
grown on plastic or imbedded in collagen. Although growth
in a 3-D collagen matrix largely eliminated expression of the
PAR-2 protein, however, the mRNA remained at a basal
level (Fig 9).
Discussion
A myriad of reports over several decades have described
mast cell hyperplasia arising in fibrosing tissue regardless of
the underlying diagnosis (Gruber, 1995; Gruber et al, 1997).
Both in normal reparative and pathologic wound healing,
Figure 4
Immunoblots demonstrate PAR-2 expression in a wide survey of
different fibroblast cell lines. PAR- 2 was visualized using goat po-
lyclonal antibody recognizing NH-terminus of human PAR-2 in cell
lysates (prepared by NP-40 detergent lysis buffer of confluent cells) and
loaded with protein content 3–10 mg per lane. The fibroblasts originated
from varying organs and donors, including fetal male lung MRC-5 (lane
1), fetal female lung AGO4393 (lane 2), fetal female skin AGO4392 (lane
3), fetal male lung AGO4526 (lane 4), fetal male skin AGO4525 (lane 5),
adult 35 female lung AGO2603 (lane 6), adult 35 female skin AGO2602A
(lane 7), adult 61 male lung AGO2262 (lane 8), adult 61 male skin
AGO2261A (lane 9). Note that the core protein at 44 kDa is present in all
the fibroblasts.
Figure5
Effect of collagen on PAR-2 expression. (A) Immunoblot demon-
strating PAR-2 expression of fibroblasts cultured as monolayers on the
surface of extracellular matrix. Fibroblasts 2261B cultured using stand-
ard conditions in plastic dishes (lane 1) were compared to fibroblasts
layered on type I collagen (lane 2) or fibronectin (lane 3) for up to 72 h.
Note the lack of any change in PAR-2 expression despite varying culture
conditions. The immunoblot shown is representative from three sepa-
rate experiments. (B) Immunoblot of PAR-2 expression in fibroblasts
embedded in collagen matrices. Cells cultured within three-dimensional
collagen gels exhibited marked attenuation of 44 kDa PAR-2 core pep-
tide expression as compared to standard culture conditions. Shown is
fibroblast PAR-2 expression on plastic dishes in serum-free media as
per standard culture conditions (lanes 1, at time ponts indicated), com-
pared to PAR-2 expression after initiating growth within collagen gels at
24 and 48 h in the presence and absence of serum (lanes 2 and 3; 24
and 48 h as shown). The immunoblot is representative from four sep-
arate experiments. (C). Immunostaining of 2261B fibroblasts indicating
PAR-2 expression under standard culture conditions (left panel) com-
pared to growth within collagen matrices (right panel). Fibroblast cell
lines were grown in collagen for 48 h, harvested as described in Ma-
terials and Methods, and then deposited onto slides, fixed, permeabli-
zed and stained with polyclonal antibody to PAR-2 followed by anti-goat
IgG-Alexa 488. Note the intense PAR-2 staining when cultured under
standard monolayer conditions in plastic dishes and the marked atten-
uation of staining when cultured within collagen matrices.
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mast cells have been found in increased numbers at sites of
excessive tissue remodeling (Lee Choi and Claman, 1987;
Rothe and Kerdel, 1991). This observation lends support to
the notion that mast cells and fibroblasts interact in a man-
ner leading to a fibrogenic cascade. Numerous cell cocul-
ture studies have provided evidence to substantiate this
concept. Taken together, the published studies document
that mast cell products have the capacity to augment fib-
roblast proliferation, chemotaxis, matrix synthesis, and my-
ofibroblast transformation (Gruber, 2003).
A major product produced uniquely by human mast cells
is the serine protease tryptase (20). Tryptase is capable of
activating fibroblasts and thus has been considered a po-
tent fibrogenic factor (Gruber et al, 1997). Furthermore, the
mechanism by which tryptase activates cells has been at-
tributed to its capacity to cleave PAR-2 (Corvera et al, 1997;
Mirza et al, 1997; Molino et al, 1997; Schechter et al, 1998;
Steinhoff et al, 1999; Compton et al, 2001; Akers et al,
2002), a seven transmembrane G-protein receptor distin-
guished by a unique mechanism of self-activation following
enzymatic cleavage (Macfarlane et al, 2001).
Although substantial data demonstrate the ability of try-
ptase to activate fibroblasts via a proteolytic mechanism,
previous studies depict minimal if any expression of its pu-
tative receptor PAR-2 on tissue fibroblasts under normal
conditions in vivo (Santulli et al, 1995; D’Andrea et al, 1998).
However, in pathologic states or during wound healing,
D’Andrea et al (2001) noted distinct PAR-2 expression on
stromal fibroblasts immediately surrounding the underlying
process. Thus, it seems plausible that although quiescent
tissue fibroblasts constitutively express minimal PAR-2
in vivo, conditions that promote fibroblast proliferation or
activation might induce PAR-2 expression. In this report, we
present experimental data to confirm this hypothesis. We
specifically identified PDGF-BB and TGF-b as potent in-
ducers of fibroblast PAR-2 expression and provide evidence
to substantiate that extracellular matrix may downregulate
its expression.
Previous publications have differed in terms of fibroblast
capacity to express PAR-2. Initial studies characterizing the
distribution of PAR-2 noted relatively high levels in certain
lung fibroblasts but absent or much lower levels in dermal
fibroblasts (Schechter et al, 1998; Akers et al, 2002). Cer-
tainly, methodological differences, as well as possible fib-
roblast heterogeneity, and staining techniques may have
accounted for some of these different observations. Our
contention that PAR-2 expression is subject to regulation
was initially supported in endothelial cells by the finding of
Figure 6
Immunoblots of fibroblasts indicating the effect of growth factors
on PAR-2 expression. Cultures of adult dermal fibroblasts were grown
for 9 days without feeding, washed, and treated for 72 h with serum-
free medium containing no growth factors (lane 1), TGF-b at 5 ng per
mL (lane 2), PDGF-BB at 30 ng per mL (lane 3), or both PDGF-BB and
TGF-b (lane 4). Note increased 44 kDa PAR-2 expression with the ad-
dition of the growth factors. The immunoblot shown is representative
from five separate experiments.
Figure 7
Immunoblot demonstrating inducible PAR-2 expression in a dose-
dependent fashion in response to exogenous PDGF-BB. Cultures of
2261B fibroblasts were grown on tissue culture plates in serum-free
media with varying amounts of PDGF-BB (3–100 ng per mL) for 72 h;
cells were then lysed for immunoblotting to assess a dose response for
PAR-2 expression. Densitometric analysis of the 44 kDa core receptor
is shown as absorbance units. The immunoblot shown is representative
from three separate experiments.
Figure8
Immunoblot demonstrating inducible PAR-2 expression with
PDGF-BB despite embedding fibroblasts within a collagen matrix.
Fibroblast cultures 4392A were grown as described in Materials and
Methods in three-dimensional collagen gels to minimize PAR-2 ex-
pression for varying incubation periods as indicated. PDGF-BB at 30 ng
per mL was added at the time of gel formation (n¼ 3). Densitometric
analysis of the 44 kDa core receptor is shown as absorbance units in
this representative immunoblot at 24 and 48 h as indicated.
Figure9
RT-PCR demonstrating increased PAR-2 mRNA expression with
PDGF-BB in fibroblasts on plastic and within a collagen matrix.
Fibroblasts (4392A) were grown on plastic as described in Materials
and Methods or in three-dimensional collagen gels to minimize PAR-2
expression for 24 h. PDGF-BB at 30 ng per mL was added at the time
of collagen gel formation.
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inducible PAR-2 expression following exposure to inflam-
matory cytokines, such as tumor necrosis factor-a and
interleukin-1 (Nystedt et al, 1996). Thus, the observed
differences in PAR-2 expression between lung and skin fib-
roblasts may primarily reflect differences in the growth con-
ditions provided by their native tissues in vivo, as well as
differences in their responses to culture conditions in vitro.
Our data studying human fibroblasts in vitro demon-
strates unequivocally PAR-2 expression in numerous cul-
tures of both lung and skin fibroblasts (Fig 4). This included
different fibroblast cultures from adult, neonatal, and fetal
skin, as well as adult and fetal lung. PAR-2 expression
seemed largely independent of tissue source, age of donor,
and number of population doublings in culture. We also
observed that MRC-5 fetal lung fibroblasts, which have
previously been reported to respond to tryptase as a mi-
togen (Cairns and Walls, 1997), strongly expressed PAR-2.
Similarly, the foreskin fibroblasts AG01523, which we pre-
viously demonstrated could be activated by tryptase (Gailit
et al, 2001), also expresses PAR-2 and is supportive evi-
dence that the expressed PAR-2 is functional, although ad-
ditional studies will be required to confirm this notion.
Since the expression of PAR-2 appeared to be a con-
sistent property of cultured fibroblasts, we investigated the
regulation of PAR-2 expression to further understand the
relative absence of PAR-2 under normal condition, in vivo.
Many phenotypic properties change during the differentia-
tion of fibroblasts into myofibroblasts, and the expression of
PAR-2 may be among them (Dery et al, 1998; D’Andrea et al,
2001; Akers et al, 2002). We presume that myofibroblast
transformation is associated with PAR-2 expression, since
TGF-b1 and PDGF-BB, two growth factors most closely
linked to induction of myofibroblast proliferation and differ-
entiation in vivo, stimulated PAR-2 expression (Desmouliere
et al, 1993; Grinell, 2003). In addition, we documented a
marked reduction in PAR-2 expression in fibroblasts when
embedded within an extracellular matrix, thus simulating
normal organ tissue conditions with fibroblasts sustained in
a low proliferative state (Grinell, 2003).
In summary, this study provides definitive data support-
ing the concept that fibroblasts are capable of expressing
cell surface PAR-2 and thus becoming responsive to try-
ptase activation by mast cells and this expression is subject
to downregulation by local microenvironmental conditions
and induction by paracrine growth factors. The flow cyto-
metry, as well as the immunohistological studies, indi-
cate that the PAR-2 receptor peptide is present in both the
cytoplasm and expressed on the membrane of these fib-
roblasts. Additional studies will thus be required to precisely
determine and characterize the functionality of this receptor
under varying conditions. Future studies concerning the
regulation of PAR-2 expression and its function in disorders
characterized by abnormalities in fibroblast–mast cell inter-
actions should yield further insight into the specific role of
PAR-2 in the disease process.
Materials and Methods
Cell culture The following cultures of normal human fibroblasts
were obtained from the National Institute on Aging, Aging Cell Cul-
ture Repository, Coriell Institute for Medical Research (Camden,
NJ): adult lung (AG0-2262, 2603), fetal lung (AG0-4393, 4526), adult
skin (AG0-4145, 5186, 4453, 10047, 2261B, 6290, 7471, 2602, and
5838), neonatal skin (AG0-1523, 8498), and fetal skin (AG0-4392A,
4525). Each culture of lung fibroblasts (AG0-2262, 2603, 4393,
4526) was matched with a corresponding culture of skin fibroblasts
(AG0-2261B, 2602, 4392A, 4526) obtained from the same donor.
Three other cultures of fetal lung fibroblasts, MRC-5, IMR-90, and
WI-38, were also obtained from the Coriell Institute. All fibroblast
cultures were grown in minimum essential medium containing
Earle’s salts, and 26 mM sodium bicarbonate, 25 mM HEPES, pH
7.3 (Life Technologies, Gaithersburg, Maryland), supplemented with
non-essential amino acids (Life Technologies), 10% fetal bovine
serum (HyClone Laboratories, Logan, Utah), and 100 U per mL
penicillin and 100 mg per mL streptomycin. The serum-free medium
(SF-MEM) used in the experiments described below was identical
to the fibroblast growth medium except that it contained 2 mg per
mL BSA (low endotoxin, fatty acid free; ICN Biomedical Research
Products, Costa Mesa, California) instead of serum. The population
doubling (PDL) of the fibroblast cultures used ranged from 15 to 25,
but several cultures with high numbers of population doublings
were also included for specific experiments. All cell cultures were
maintained in an atmosphere of air and 5% CO2 at 371C.
Immunoﬂuorescence Studies For PAR-2 surface analysis by
flow cytometry, cells were detached using non-enzymatic tech-
niques (Cell Stripper, Cellgro, Fisher Scientific, Springfield, New
Jersey), washed in staining buffer (PBS (phosphate-buffered sa-
line), 0.1% sodium azide, 1% BSA), and then incubated with either
a monoclonal (clone sc-13504 at 1 mg perp106 cells) or polyclonal
PAR-2 Ab (clone sc-82061 at 0.3 mg perp106 cells) or with isotype-
matched control Abs (Becton-Dickinson/Pharmingen, Sunnyvale,
Califonia; Sigma, St Louis, Missouri) for 45 min on ice. Both anti-
PAR Abs were obtained from Santa Cruz Biotechnology (Santa
Cruz, California), were generated against N-terminal peptides, and
both reacted with cleaved and uncleaved PAR-2. After incubation
with primary Ab, cells were incubated for 30 min on ice with sec-
ondary Ab linked to Alexa fluor 488 (Molecular Probes, Eugene,
Oregon) and then fixed in 1% buffered formalin in PBS. For as-
sessment of total PAR-2 cell staining (surface and intracellular)
by flow cytometry, cells were detached from cultures using
non-enzymatic techniques, fixed and permeabilized with fixing/
permeabilizing solution (Becton Dickinson) at room temperature and
then stained with primary and secondary Abs. Analysis was per-
formed on a FACSort flow cytometer (Becton Dickinson) calibrated
with Calbrite beads (Becton Dickinson). The distribution of debris
and dead cells was assessed on the basis of forward and right
angle scatter before proceeding with the analysis. A total of
5–10,000 events were examined using a 488 nm wavelength ex-
citation. Acquired events were analyzed using Cell Quest Software
(Becton Dickinson). Results are expressed as % positive cells.
Microscopic visualization of total and surface staining was per-
formed after depositing labeled cells onto slides by cytocentrifu-
gation, and counterstaining with propidium iodide (15 mg per mL).
For total in situ PAR-2 cell staining and confocal microscopy
(at the Microscopy Imaging Center, SUNY, Stony Brook, New York),
cells were grown in chamber slides (Lab Tek, Fisher Scientific),
fixed in 10% PBS-buffered formalin and permeabilized with perm-
eabilizing solution (Becton Dickinson) at room temperature and
then stained with primary and secondary Abs. Single indirect
staining for smooth muscle actin (SMA) employed monoclonal Ab
(Sigma, 1 mg perp106 cells) and isotype controls (Becton Dickinson/
Pharmigen) and secondary Ab linked to Alexa 488 (Molecular
Probes). Double IF labeling for PAR-2 and SMA by either flow
cytometry or microscopy employed indirect staining methods for
PAR-2 and direct staining with anti-SMA linked to Cy3 (mouse
monoclonal IgG, Sigma) or isotype control Ab linked to Cy5 (Jack-
son Immunoresearch Laboratories, Westgrove, Pennsylvania).
Gel electrophoresis and immunoblotting Cell cultures were
washed twice with cold PBS and then immediately lysed with cold
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lysis buffer (20 mM sodium phosphate, pH 7.2, 120 mM NaCl,
10 mM NaF, 0.1% SDS, 1.0% NP-40) containing protease and
phosphatase inhibitors (5 mg per mL leupeptin, 5 mg per mL
E-64, 10 mg per mL chymostatin, 5 mg per mL pepstatin A, 2 mg per
mL aprotinin, 1 mM AEBSF, 1 mM 1,10-phenanthroline, 1 mM
EGTA, 1 mM EDTA, and 1 mM sodium orthovanadate). Fibroblast
cultures were lysed at 80%–100% confluence, using approximate-
ly 1 mL of lysis buffer per 2  106 cells, by scraping the bottom of
the flask with a rubber policeman to ensure thorough extraction of
the monolayer. Lysates were cleared by centrifugation at 10,000
rpm for 10 min at 41C. Protein concentration in cell lysates was
determined with the BCA protein assay (Pierce, Rockford, Illinois),
using the supplied BSA as a standard. Lysate aliquots were pre-
pared for electrophoresis in Laemmeli sample buffer containing 5%
2-mercaptoethanol and 2 M urea. Equal amounts of protein from
each lysate sample, typically 3–10 mg, were separated on a 10% or
12% Tris-HCl Ready Gel (Bio-Rad Laboratories, Hercules, Califor-
nia) and then electrophoretically transferred to Immobilon-P
membrane (Millipore, Bedford, Massachusetts). Membrane blots
were washed briefly in PBS containing 0.1% Tween-20 (PBS/Tw),
blocked in PBS/Tw plus 1% non-fat dry milk and then incubated at
room temperature for 60 min with primary antibody diluted in PBS/
Tw plus 0.1% non-fat milk and 30 mg per mL rabbit IgG. Immuno-
blots were then washed and incubated at room temperature for 40
min with alkaline phosphatase conjugate (rabbit anti-goat; Zymed
Laboratories, South San Francisco, California) diluted 1:3000 and
stained by incubation with BCIP/NBTsubstrate (Kirkegaard & Perry
Laboratories, Gaithersburg, Maryland). The molecular weights of
stained bands on immunoblots were estimated from a standard
curve based on the relative mobilities of prestained SDS-PAGE
standards (Bio-Rad Laboratories).
Goat polyclonal antibodies, specifically recognizing the amino
terminus of human PAR-2, designated antibody PAR-2 (N-19), and
the carboxy terminus, designated antibody PAR-2 (C-17), and
PAR-2 antigenic blocking peptides were purchased from Santa
Cruz Biotechnology. The specificity of the PAR-2 antibodies was
determined by pre-absorbing the antibodies with the PAR-2 block-
ing peptide at 41C for 2 h prior to performing the immunoblots and
comparing the staining patterns to the standard immunoblot
conditions.
Induction of PAR-2 expression Two different experimental proto-
cols were used to test the effects of growth factors and cytokines
on expression of PAR-2 by normal human dermal fibroblasts. The
essential difference between the experiments was the methodol-
ogy used to produce quiescent cell cultures. In some experments,
fibroblasts were seeded into culture flasks at a starting density of
about 12,000 cells per cm2. The cells were grown for 9 d in their
original medium (D’Andrea et al, 2001), washed three times with
SF-MEM, and then exposed to SF-MEM containing the specified
factors or cytokines and incubated for 72 h. In other experiments,
fibroblasts were seeded into 6-well plates at a similar starting
density, but these cells were only grown for 2 d in the original
medium, and then they were washed twice with PBS, fed SF-MEM,
starved for 2 d, and then exposed to SF-MEM containing growth
factors or cytokines and incubated for 72 h. At the end of the
treatment period, the effects of the various factors on the expres-
sion of PAR-2 were analyzed using the immunoblotting procedure
described above. TGF-b1 purified from human platelets, recom-
binant human PDGF-BB, recombinant human IL-1, and recom-
binant human TNF-a were purchased from R&D Systems
(Minneapolis, Minnesota).
RT-PCR assay Total cellular RNA was extracted from the cells
using TRIzol (Invitrogen, Carlsbad, California) according to man-
ufacturer’s instructions. Oligo dT-primed reverse transcription was
performed in 2 mg of total RNA in a 20 ml reaction volume (Gene
Amp RNA PCR, Applied Biosystems, Foster City, California). The
primers used for PCR were as follows: PAR-2 forward primer:
50- TTG ATG GCA CAT CCG ACG TC-30, PAR-2 reverse primer:
50- AAT ACC TCT GCA CAC TGA GGC AG-30; GAPDH forward
primer: 50- CTA CAA TGA GCT GCG TGT GG-30, GAPDH reverse
primer: 50- AAG GAA GGC TGG AAG AGT GC-30. The primers were
constructed to generate fragment of 385 bp for PAR-2 and 527 bp
for GAPDH. Cycling conditions were as follows: 951C for 1 min,
601C for 1 min, and 721C for 1 min for 35 cycles. Amplified samples
were visualized on 2% agarose gel stained with ethidium bromide
and photographed under UV light.
Regulation of PAR-2 expression by matrix Cells grown on col-
lagen: Two fibroblast cell lines, 4392A and 2261B, were cultured in
DMEM with 10% FBS, 1% PSM at a concentration of 5  104 cells
per well. Cells were grown on either untreated tissue culture plastic
or dishes coated with type I collagen or fibronectin (Biocoat cell-
ware, Becton Dickinson). The cells were allowed to attach over-
night and then starved for 24 h in DMEM with 2% BSA and
incubated up to 72 h at 371C, 5% CO2 in DMEM culture media
before washing and lysing with 1% octylglucoside in 50 mM HE-
PES pH 7.4 to which was added protease and phosphatase in-
hibitors as previously noted. Protein concentration was determined
with the BCA protein assay (Pierce) and lysate was loaded onto
12% SDS gels for PAGE (Bio-Rad, Hercules, California) and then
transferred for immunoblotting.
Cells grown in collagen matrix Collagen gels were made by
adding collagen (Vitrogen, Cohesion, Palo Alto, California) that had
been neutralized with NaOH to fibroblasts (4392A or 2261B) for a
final concentration of 5  104 cells/well in six-well tissue culture
plates (Falcon, Becton Dickinson) with or without PDGF-BB 30 ng
per mL (R&D Systems) and then the mixture was allowed to gel.
The gels were suspended in DMEM, 10% FCS, 1% PSM and in-
cubated 24 and 48 h at 371C, 5% CO2. The collagen gels were
dispersed with collagenase 10 ug per mL (Sigma, St Louis, MO) to
liberate the cells which were then washed and lysed with 1% oct-
ylglucoside in 50 mM HEPES pH 7.4 to which was added protease
and phosphatase inhibitors as previously noted. Protein concen-
tration was determined with the BCA protein assay (Pierce) and
lysate was loaded onto 12% SDS gels for PAGE (Bio-Rad, Her-
cules, CA) and then transferred to membranes for immunoblotting.
Cells grown in an organotypic skin equivalent In order to mimic
an in vivo environment for PAR-2 expression, organotypic skin
cultures were prepared as described previously (Garlick and
Taichman, 1994; Gruber et al, 1997). The culture system used
consisted of a polymerized collagen gel matrix with embedded
human foreskin fibroblasts that served as a biologic substructure
to support growth and stratification of human foreskin keratin-
ocytes. Organotypic cultures or rafts were grown submerged for 5
d and then raised to the air interface for another 5 d to allow for
complete stratification and differentiation of surface keratinocytes.
We have used this skin-equivalent culture system previously to
study interactions between mast cells and dermal fibroblasts since
it manifests epithelial stratification and mimics other properties of
living skin (Gruber et al, 1997).
Statistical analyses Statistical differences between flow cytome-
try samples were analyzed by using a two-tailed Student’s t test.
The results of the immunoblots were analyzed by densitometry
from scanned images and the absorbance units per band were
quantified using NIH Image software.
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